Stocks / NASDAQ / Immuneering Corporation

Immuneering Corporation

Our Opinion

Immuneering Corporation is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they use animals for product testing.

“Preclinical data showed broad activity in multiple animal models bearing tumors with diverse RAS and RAF mutations, including KRAS-G12C, KRAS-G12D, KRAS-G12S, NRAS-Q61R and BRAF-V600E. Further, IMM-1-104 demonstrated superior activity and tolerability versus other U.S. FDA registered MEK inhibitors in head-to-head animal studies.” Read the following article

Company Description

Immuneering Corporation is a biopharmaceutical company. The Company is focused on improving patient outcomes by advancing a pipeline of oncology and neuroscience product candidates developed using its translational bioinformatics platform. Its development programs in oncology are focused on providing treatments for patients with solid tumors caused by mutations of the MAPK and mTOR pathways.

Company Website: https://immuneering.com